Showing 1 - 10 of 174
Loving the lizards
Oped, Postbag, Published on 18/03/2026
» Re: "It's not just the park's lizards", (BP, March 16) & "Monitor monitoring", (BP, April 26, 2025).
What would happen if Khamenei falls?
Oped, Gwynne Dyer, Published on 05/01/2026
» The demonstrations began again in Iran last week, only two years after the "Woman, Life, Freedom" movement convulsed the country for months. However, the current protests are potentially much broader than that episode because they are driven by the collapse in Iran's currency, the rial (now 1,420,000 to the US dollar), and the explosive rise in the cost of living.
Institutional redesign in order for economic change
News, Diane Coyle, Published on 30/12/2025
» The Nobel Prize in economics was awarded both this year and last year to scholars who, in different ways, emphasised the importance of institutions to economic growth.
Time for Indo-Pacific unity is now
Oped, Akihisa Nagashima, Published on 26/12/2025
» We are living in an age of global disruption. Supply chains are being reconfigured to avoid dependence on any one producer or country. Trade ties are being upended by high and unpredictable tariffs (and the threat of more). Longstanding alliances are being strained by doubts about partners' reliability.
The treacherous sycophancy of the populists
Oped, Michael Burleigh, Published on 15/12/2025
» Until a few days ago, it had never crossed my mind that people across Europe -- including Londoners like me -- were living in a strife‑afflicted hell hole, "suffocated" by regulations, stripped of political liberties, and bound for "civilisational erasure". So, it was with some surprise that I read this assessment in the new US National Security Strategy -- a document that echoes pseudo‑intellectual propaganda more than resembling any serious foreign‑policy analysis.
AI as Asia's new growth engine?
Oped, Lee Jong-wha, Published on 27/11/2025
» Two decades after globalisation fuelled a global economic boom, growth has shifted onto a more subdued path, where it is likely to remain for the foreseeable future. Beyond the immediate shock of fragmenting trade and investment ties -- a result of rising geopolitical tensions, particularly between the United States and China -- lie structural headwinds, including population ageing, stagnant productivity, and the growing costs of inequality and natural disaster. These challenges strike at the heart of Asia's growth model.
A paradigm shift for animal tests
Oped, Peter Singer & Sankalpa Ghose, Published on 17/10/2025
» Even in an era of intense political polarisation, there are still moments when a bipartisan consensus can emerge around important ethical issues. One such moment is happening now. Last April, the United States Food and Drug Administration released its "Roadmap to Reducing Animal Testing in Preclinical Safety Studies". The FDA said that it was taking "a groundbreaking step" that would advance public health and limit wasteful expenditure by replacing animal testing with "more effective, human-relevant methods".
When societies rise, fall, and face catastrophe
News, Antara Haldar, Published on 11/10/2025
» When the United Nations emerged from the rubble of two world wars 80 years ago, it represented humanity's most ambitious attempt ever to turn catastrophe into cooperation. But while the scarred world of 1945 had hope following the Allied victory, that optimism has since curdled. The UN today is underfunded, risk-averse, and paralysed.
Authoritarians' brave new cities
Oped, Robert Muggah & Carlo Ratti, Published on 23/09/2025
» Few policy ideas are as radical -- or as misleadingly packaged -- as "freedom cities". Championed by Silicon Valley's techno-libertarian elite and recently embraced by right-wing politicians like Donald Trump, the idea is to create digitally powered, master-planned enclaves of deregulated innovation.
Terminal volunteers can save lives
News, Peter Singer & Benjamin L Sievers, Published on 13/09/2025
» At the University of California, San Diego (UCSD), a programme called Last Gift offers terminally ill patients the opportunity to help create more effective treatments. Their special circumstances transform the usual risk-benefit calculus of joining a clinical study of an untested drug. Researchers can ask them to consider consenting to being research participants in ways that they would not ask healthier people with long life expectancies, and terminally ill patients may choose to give that consent when others would be less likely to do so.